CENPL and breast carcinoma: Further, the TIMER and GEPIA analysis showed that the transcriptional levels of CENPL in various cancer types, such as HCC, lung cancer, pancreatic cancer, ovarian cancer, breast cancer, gallbladder cancer, cervical cancer, esophageal cancer, glioblastoma multiforme Tumor, bladder urothelial carcinoma, were significantly higher than that in normal tissues (Supplementary Figures 1 and 2).